| scholarly article | Q13442814 |
| P50 | author | Vijay K. Yadav | Q37830303 |
| Claudia Waskow | Q42176418 | ||
| Elvira Mass | Q57400788 | ||
| P2093 | author name string | Frederic Geissmann | |
| Gerard Karsenty | |||
| Martina Rauner | |||
| Lucile Crozet | |||
| Tomi Lazarov | |||
| Jiri Eitler | |||
| Gulce I Percin | |||
| Pierre-Louis Loyher | |||
| Christian E Jacome-Galarza | |||
| Mathieu Bohm | |||
| James T Muller | |||
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| Central control of fever and female body temperature by RANKL/RANK | Q24321735 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus | Q24797230 | ||
| Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency | Q28284581 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis | Q29614347 | ||
| A robust and high-throughput Cre reporting and characterization system for the whole mouse brain | Q29616609 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
| Successful bone-marrow transplantation for infantile malignant osteopetrosis. | Q33483311 | ||
| A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis | Q33597235 | ||
| Pyknodysostosis | Q33972531 | ||
| Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero | Q34078646 | ||
| Hematopoietic stem cell transplantation for infantile osteopetrosis | Q34477968 | ||
| Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts | Q34679499 | ||
| A review on current osteoporosis research: with special focus on disuse bone loss. | Q35178427 | ||
| Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification | Q35950201 | ||
| Specification of tissue-resident macrophages during organogenesis. | Q37343167 | ||
| The stream of precursors that colonizes the thymus proceeds selectively through the early T lineage precursor stage of T cell development | Q38271118 | ||
| A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis | Q38335144 | ||
| The developmental relationship between osteocytes and osteoclasts: A study using the quail-chick nuclear marker in endochondral ossification | Q40878060 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| Distinct Sources of Hematopoietic Progenitors Emerge before HSCs and Provide Functional Blood Cells in the Mammalian Embryo | Q41465852 | ||
| Clonal expansion capacity defines two consecutive developmental stages of long-term hematopoietic stem cells | Q41945096 | ||
| Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects | Q43833399 | ||
| Bone-marrow transplantation in osteopetrosis | Q43871072 | ||
| Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues | Q48189802 | ||
| Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors | Q48425484 | ||
| SETD1A protects HSCs from activation-induced functional decline in vivo | Q49954468 | ||
| Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. | Q50647275 | ||
| Histological analysis of GFP expression in murine bone. | Q50769414 | ||
| Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. | Q51035051 | ||
| Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. | Q52085270 | ||
| Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. | Q54528928 | ||
| Osteoclasts derived from haematopoietic stem cells | Q59056486 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| CSF1R regulates the dendritic cell pool size in adult mice via embryo-derived tissue-resident macrophages | Q59789336 | ||
| Bone-marrow transplantation in osteopetrosis | Q66696904 | ||
| Bone Resorption Restored in Osteopetrotic Mice by Transplants of Normal Bone Marrow and Spleen Cells | Q66903767 | ||
| Osteopetrosis cured by temporary parabiosis | Q69522242 | ||
| Marrow transplantation for juvenile osteopetrosis | Q70151298 | ||
| Characterization of osteoclast precursors in human blood | Q73309559 | ||
| P433 | issue | 7753 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 541-545 | |
| P577 | publication date | 2019-04-10 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Developmental origin, functional maintenance and genetic rescue of osteoclasts | |
| P478 | volume | 568 |
| Q94649076 | Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1 |
| Q92453638 | Erythromyeloid progenitors give rise to a population of osteoclasts that contribute to bone homeostasis and repair |
| Q104802177 | Gaucher disease: Basic and translational science needs for more complete therapy and management |
| Q92648277 | Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis |
| Q92239539 | Glucocorticoids Shape Macrophage Phenotype for Tissue Repair |
| Q99414171 | Heterogeneity and Actin Cytoskeleton in Osteoclast and Macrophage Multinucleation |
| Q91639069 | Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions |
| Q98771175 | Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma |
| Q104466224 | Making and Shaping Endochondral and Intramembranous Bones |
| Q64967677 | Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. |
| Q92332913 | Microglia in the developing retina |
| Q111019276 | Neuropilin‐1‐Mediated SARS‐CoV‐2 Infection in Bone Marrow‐Derived Macrophages Inhibits Osteoclast Differentiation |
| Q99365388 | Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation |
| Q89967663 | RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies |
| Q90567814 | Role of APD-Ribosylation in Bone Health and Disease |
| Q104111440 | Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution |
| Q93006830 | TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression |
| Q98499841 | The M-CSF receptor in osteoclasts and beyond |
| Q92857858 | The Mononuclear Phagocytic System. Generation of Diversity |
Search more.